{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:50:33Z","timestamp":1779313833764,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40256-017-0242-3","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T14:32:04Z","timestamp":1501857124000},"page":"465-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States"],"prefix":"10.1007","volume":"17","author":[{"given":"Raymond G.","family":"Schlienger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Wehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lopez Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Yeaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"issue":"4","key":"242_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.iac.2006.08.001","volume":"26","author":"JB Byrd","year":"2006","unstructured":"Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin N Am. 2006;26(4):725\u201337.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"8","key":"242_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","volume":"24","author":"A Agostoni","year":"2001","unstructured":"Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599\u2013606.","journal-title":"Drug Saf"},{"issue":"1","key":"242_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-6-14","volume":"6","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010;6(1):14.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"7","key":"242_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/psb.358","volume":"17","author":"I Salih","year":"2006","unstructured":"Salih I, Thomas S. Causes and management of drug-induced angioedema. Prescriber. 2006;17(7):14\u20138.","journal-title":"Prescriber"},{"issue":"6","key":"242_CR5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/HYPERTENSIONAHA.108.111393","volume":"51","author":"MA Weber","year":"2008","unstructured":"Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension. 2008;51(6):1465\u20137.","journal-title":"Hypertension"},{"issue":"1","key":"242_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11882-011-0238-z","volume":"12","author":"M Vasekar","year":"2012","unstructured":"Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012;12(1):72\u20138.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"242_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","volume":"60","author":"NJ Brown","year":"1996","unstructured":"Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60(1):8\u201313.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"242_CR8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","volume":"51","author":"DR Miller","year":"2008","unstructured":"Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51(6):1624\u201330.","journal-title":"Hypertension"},{"issue":"20","key":"242_CR9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M, Ross SM, Ding X, Hernandez AF, et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med. 2012;172(20):1582\u20139.","journal-title":"Arch Intern Med"},{"issue":"4","key":"242_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/14740338.2012.696608","volume":"11","author":"F Angeli","year":"2012","unstructured":"Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Verdecchia P. Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview. Expert Opin Drug Saf. 2012;11(4):659\u201370.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"242_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1470320313491997","volume":"16","author":"K Joseph","year":"2015","unstructured":"Joseph K, Tholanikunnel TE, Kaplan AP. In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme. J Renin Angiotensin Aldosterone Syst. 2015;16(2):321\u20137.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"242_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","volume":"110","author":"H Makani","year":"2012","unstructured":"Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012;110(3):383\u201391.","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"242_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pds.2327","volume":"21","author":"G Schneider","year":"2012","unstructured":"Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, et al. A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):240\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"242_CR14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.amjcard.2011.11.014","volume":"109","author":"JR Roberts","year":"2012","unstructured":"Roberts JR, Lee JJ, Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol. 2012;109(5):774\u20135.","journal-title":"Am J Cardiol"},{"issue":"9","key":"242_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1524-6175.2006.05689.x","volume":"8","author":"LB Piller","year":"2006","unstructured":"Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2006;8(9):649\u201356.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"14","key":"242_CR16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","volume":"165","author":"JB Kostis","year":"2005","unstructured":"Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637\u201342.","journal-title":"Arch Intern Med"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-017-0242-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T16:03:39Z","timestamp":1511539419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-017-0242-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s40256-017-0242-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}